SIM
IMMU

Spark Investment Management’s Immunomedics Inc IMMU Stock Holding History

Spark Investment Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-81,900
Closed -$723K – 853
2017
Q2 		$723K Buy
+81,900
New +$575K 0.04% 446
2013
Q4 		– Sell
-54,700
Closed -$339K – 726
2013
Q3 		$339K Buy
54,700
+29,800
+120% +$172K 0.08% 350
2013
Q2 		$135K Buy
+24,900
New +$81.8K 0.04% 369

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Spark Investment Management's IMMU Position: Q3 2017 in Review

Spark Investment Management sold out of Immunomedics Inc (IMMU) in Q3 2017, closing a stake of 81,900 shares — an estimated $723K sold.

Spark Investment Management first reported a position in IMMU in Q2 2013 and held it in 3 quarters. The position peaked at $723K in Q2 2017. 150 funds tracked by Wall St. Rank hold IMMU as of Q3 2017.

  • Spark Investment Management reported no remaining Immunomedics Inc position as of Q3 2017 after selling out during the quarter.
  • Spark Investment Management sold 81,900 Immunomedics Inc shares in Q3 2017, an estimated $723K.
  • Spark Investment Management first reported a position in Immunomedics Inc in Q2 2013 and held it in 3 quarters.
  • Spark Investment Management's Immunomedics Inc position peaked at $723K in Q2 2017.
  • 150 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2017.

Based on Spark Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.